Nalaganje...
How I use hydroxyurea to treat young patients with sickle cell anemia
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides therapeutic benefit through multiple mechanisms of action. Over the past 25 years, substantial experience has accumulated regarding its safety and efficacy for patients with SCA. Early proof-of-principle...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2010
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2902131/ https://ncbi.nlm.nih.gov/pubmed/20223921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-04-146852 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|